About 2-[3-[(3-cyanophenyl)carbamoylamino]-5-(morpholin-4-ylmethyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-methyl-N-phenylacetamide
2-[3-[(3-cyanophenyl)carbamoylamino]-5-(morpholin-4-ylmethyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-methyl-N-phenylacetamide (PubChem CID 23373656) has the molecular formula C31H31N7O4
and a molecular weight of 565.63 g/mol. Its IUPAC name is 2-[3-[(3-cyanophenyl)carbamoylamino]-5-(morpholin-4-ylmethyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-methyl-N-phenylacetamide.
Molecular Properties
| Compound Name | 2-[3-[(3-cyanophenyl)carbamoylamino]-5-(morpholin-4-ylmethyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-methyl-N-phenylacetamide |
| PubChem CID | 23373656 |
| Molecular Formula | C31H31N7O4 |
| Molecular Weight | 565.63 g/mol |
| Exact Mass | 565.24 |
| IUPAC Name | 2-[3-[(3-cyanophenyl)carbamoylamino]-5-(morpholin-4-ylmethyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-methyl-N-phenylacetamide |
| SMILES | CN(C(=O)CN1C(=O)C(NC(=O)Nc2cccc(C#N)c2)N=C(CN2CCOCC2)c2ccccc21)c1ccccc1 |
| InChI | InChI=1S/C31H31N7O4/c1-36(24-10-3-2-4-11-24)28(39)21-38-27-13-6-5-12-25(27)26(20-37-14-16-42-17-15-37)34-29(30(38)40)35-31(41)33-23-9-7-8-22(18-23)19-32/h2-13,18,29H,14-17,20-21H2,1H3,(H2,33,35,41) |
| InChIKey | XOYKNRPKAOVGLW-UHFFFAOYSA-N |
| XLogP | 2.84 |
| TPSA | 130.37 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 565.63 |
| LogP ≤ 5 | 2.84 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze 2-[3-[(3-cyanophenyl)carbamoylamino]-5-(morpholin-4-ylmethyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-methyl-N-phenylacetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[3-[(3-cyanophenyl)carbamoylamino]-5-(morpholin-4-ylmethyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-methyl-N-phenylacetamide?
The IUPAC name of 2-[3-[(3-cyanophenyl)carbamoylamino]-5-(morpholin-4-ylmethyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-methyl-N-phenylacetamide (CID 23373656) is 2-[3-[(3-cyanophenyl)carbamoylamino]-5-(morpholin-4-ylmethyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-methyl-N-phenylacetamide.
What is the SMILES notation for 2-[3-[(3-cyanophenyl)carbamoylamino]-5-(morpholin-4-ylmethyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-methyl-N-phenylacetamide?
The canonical SMILES for 2-[3-[(3-cyanophenyl)carbamoylamino]-5-(morpholin-4-ylmethyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-methyl-N-phenylacetamide is CN(C(=O)CN1C(=O)C(NC(=O)Nc2cccc(C#N)c2)N=C(CN2CCOCC2)c2ccccc21)c1ccccc1.
What is the InChIKey of 2-[3-[(3-cyanophenyl)carbamoylamino]-5-(morpholin-4-ylmethyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-methyl-N-phenylacetamide?
The InChIKey is XOYKNRPKAOVGLW-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H31N7O4/c1-36(24-10-3-2-4-11-24)28(39)21-38-27-13-6-5-12-25(27)26(20-37-14-16-42-17-15-37)34-29(30(38)40)35-31(41)33-23-9-7-8-22(18-23)19-32/h2-13,18,29H,14-17,20-21H2,1H3,(H2,33,35,41).
What are the key properties of 2-[3-[(3-cyanophenyl)carbamoylamino]-5-(morpholin-4-ylmethyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-methyl-N-phenylacetamide?
2-[3-[(3-cyanophenyl)carbamoylamino]-5-(morpholin-4-ylmethyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-methyl-N-phenylacetamide has a molecular weight of 565.63 g/mol, XLogP of 2.84, 7 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[(3-cyanophenyl)carbamoylamino]-5-(morpholin-4-ylmethyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-methyl-N-phenylacetamide is sourced from PubChem (CID 23373656), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).